What are the recommended contraceptive methods for a postpartum woman, including timing and breastfeeding considerations?

Postpartum Contraception Recommendations

All postpartum women should receive contraceptive counseling during pregnancy with immediate postpartum long-acting reversible contraception (LARC) offered before hospital discharge, as this approach significantly reduces unintended pregnancy and short interpregnancy intervals.

Timing and Method Selection by Breastfeeding Status

For Breastfeeding Women

Progestin-only methods are the preferred first-line contraceptive options and can be initiated immediately postpartum 1:

• Progestin-only pills (POPs): Category 2 (benefits outweigh risks) from 0-21 days postpartum, then Category 1 (no restrictions) after 21 days
• Etonogestrel implant: Category 2 from 0-30 days postpartum, then Category 1 after 30 days
• DMPA injection: Category 2 from 0-30 days postpartum, then Category 1 after 30 days (Category 2 after 30 days if VTE risk factors present)
• IUDs (copper or levonorgestrel): Can be placed within 10 minutes of placental delivery (Category 2), or after 4 weeks (Category 1)

Combined hormonal contraceptives (CHCs) are contraindicated early postpartum in breastfeeding women 1:

• Category 4 (unacceptable risk) before 21 days postpartum
• Category 3 (risks outweigh benefits) from 21-30 days postpartum, particularly with VTE risk factors
• Category 3 from 30-42 days if VTE risk factors present; Category 2 without risk factors
• Category 2 after 42 days postpartum

This restriction exists due to increased VTE risk and potential interference with milk supply 2, 3.

For Non-Breastfeeding Women

All contraceptive methods have fewer restrictions 1:

• Implant: Category 1 at all postpartum timepoints
• POPs: Category 1 at all postpartum timepoints
• DMPA: Category 2 before 21 days, Category 1 after 21 days
• CHCs: Category 4 before 21 days (VTE risk), Category 3 from 21-42 days with VTE risk factors (Category 2 without), Category 1 after 42 days
• IUDs: Same timing as breastfeeding women

Immediate Postpartum LARC Insertion

LARC methods should be offered immediately postpartum (before hospital discharge) to all women, particularly those at high risk for medical complications or short interpregnancy intervals 4:

IUD Placement Timing

• Within 10 minutes of placental delivery: Optimal timing with 10% expulsion rate, but higher continuation rates (80% at 6 months) compared to delayed insertion (50% continuation) due to access barriers 4
• 10 minutes to 4 weeks postpartum: Category 2 (slightly higher expulsion risk)
• After 4 weeks: Category 1 (lowest expulsion risk)

Contraindications to Immediate LARC

Do not place IUDs immediately if 4:

• Active chorioamnionitis or untreated STI
• Known uterine cavity anomaly
• Ongoing postpartum hemorrhage
• Retained placenta requiring manual/surgical removal
• Postpartum sepsis (Category 4)

Implants are contraindicated only for current breast cancer (Category 4) 4.

Critical Timing Considerations

Ovulation can resume as early as 21 days postpartum in non-breastfeeding women 5, making the traditional 6-week postpartum visit too late for contraceptive initiation. Contraception must be discussed during pregnancy and initiated before hospital discharge 5, 6.

VTE Risk Factors Requiring Caution with CHCs

Age ≥35 years, previous VTE, thrombophilia, immobility, transfusion at delivery, peripartum cardiomyopathy, BMI ≥30 kg/m², postpartum hemorrhage, cesarean delivery, preeclampsia, or smoking 1.

Algorithm for Method Selection

1. During prenatal care: Discuss all contraceptive options and patient preferences
2. Assess breastfeeding intention:
   • If breastfeeding → Offer progestin-only methods or IUD immediately
   • If not breastfeeding → All methods available after 21 days; progestin-only or IUD immediately
3. Assess VTE risk factors: If present, avoid CHCs until after 42 days postpartum
4. Offer immediate LARC (implant or IUD) before discharge to maximize continuation rates
5. If IUD desired: Place within 10 minutes of placental delivery when feasible (after excluding contraindications)

Key Clinical Pitfalls

• Waiting until 6-week visit: Results in unnecessary pregnancies and abortions 5
• Assuming breastfeeding alone provides contraception: Only exclusive breastfeeding under specific conditions (lactational amenorrhea method) provides protection for 6 months 6
• Delaying LARC placement: Leads to 50% lower continuation rates due to missed appointments 4
• Prescribing CHCs to breastfeeding women before 6 weeks: Unacceptable VTE risk 1

The evidence strongly supports immediate postpartum LARC as the most effective strategy for preventing unintended pregnancy and optimizing birth spacing 4, 5.